IBDEI1C3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21561,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,21561,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,21562,0)
 ;;=D86.81^^70^921^44
 ;;^UTILITY(U,$J,358.3,21562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21562,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,21562,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,21562,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,21563,0)
 ;;=D86.85^^70^921^45
 ;;^UTILITY(U,$J,358.3,21563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21563,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,21563,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,21563,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,21564,0)
 ;;=D86.87^^70^921^46
 ;;^UTILITY(U,$J,358.3,21564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21564,1,3,0)
 ;;=3^Sarcoid Myositis
 ;;^UTILITY(U,$J,358.3,21564,1,4,0)
 ;;=4^D86.87
 ;;^UTILITY(U,$J,358.3,21564,2)
 ;;=^5002452
 ;;^UTILITY(U,$J,358.3,21565,0)
 ;;=D86.84^^70^921^47
 ;;^UTILITY(U,$J,358.3,21565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21565,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,21565,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,21565,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,21566,0)
 ;;=D86.0^^70^921^48
 ;;^UTILITY(U,$J,358.3,21566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21566,1,3,0)
 ;;=3^Sarcoidosis of Lung
 ;;^UTILITY(U,$J,358.3,21566,1,4,0)
 ;;=4^D86.0
 ;;^UTILITY(U,$J,358.3,21566,2)
 ;;=^5002442
 ;;^UTILITY(U,$J,358.3,21567,0)
 ;;=D86.2^^70^921^49
 ;;^UTILITY(U,$J,358.3,21567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21567,1,3,0)
 ;;=3^Sarcoidosis of Lung w/ Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,21567,1,4,0)
 ;;=4^D86.2
 ;;^UTILITY(U,$J,358.3,21567,2)
 ;;=^5002444
 ;;^UTILITY(U,$J,358.3,21568,0)
 ;;=D86.1^^70^921^50
 ;;^UTILITY(U,$J,358.3,21568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21568,1,3,0)
 ;;=3^Sarcoidosis of Lymph Nodes
 ;;^UTILITY(U,$J,358.3,21568,1,4,0)
 ;;=4^D86.1
 ;;^UTILITY(U,$J,358.3,21568,2)
 ;;=^5002443
 ;;^UTILITY(U,$J,358.3,21569,0)
 ;;=D86.89^^70^921^51
 ;;^UTILITY(U,$J,358.3,21569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21569,1,3,0)
 ;;=3^Sarcoidosis of Oth Sites
 ;;^UTILITY(U,$J,358.3,21569,1,4,0)
 ;;=4^D86.89
 ;;^UTILITY(U,$J,358.3,21569,2)
 ;;=^5002453
 ;;^UTILITY(U,$J,358.3,21570,0)
 ;;=D86.3^^70^921^52
 ;;^UTILITY(U,$J,358.3,21570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21570,1,3,0)
 ;;=3^Sarcoidosis of Skin
 ;;^UTILITY(U,$J,358.3,21570,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,21570,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,21571,0)
 ;;=D86.9^^70^921^53
 ;;^UTILITY(U,$J,358.3,21571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21571,1,3,0)
 ;;=3^Sarcoidosis,Unspec
 ;;^UTILITY(U,$J,358.3,21571,1,4,0)
 ;;=4^D86.9
 ;;^UTILITY(U,$J,358.3,21571,2)
 ;;=^5002454
 ;;^UTILITY(U,$J,358.3,21572,0)
 ;;=M35.01^^70^921^54
 ;;^UTILITY(U,$J,358.3,21572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21572,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,21572,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,21572,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,21573,0)
 ;;=M35.02^^70^921^55
 ;;^UTILITY(U,$J,358.3,21573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21573,1,3,0)
 ;;=3^Sicca Syndrome w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,21573,1,4,0)
 ;;=4^M35.02
 ;;^UTILITY(U,$J,358.3,21573,2)
 ;;=^5011788
 ;;^UTILITY(U,$J,358.3,21574,0)
 ;;=M35.03^^70^921^56
 ;;^UTILITY(U,$J,358.3,21574,1,0)
 ;;=^358.31IA^4^2
